Moderna
MRNA
#1757
Rank
NZ$19.82 B
Marketcap
NZ$50.73
Share price
-0.57%
Change (1 day)
-31.64%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$19.82 Billion

As of December 2025 Moderna has a market cap of NZ$19.82 Billion. This makes Moderna the world's 1757th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$19.82 B-27.61%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Moderna was reported to be:

NZ$19.81 Billion
by Nasdaq info icon info icon
NZ$19.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
NZ$0.97 B-95.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$431.40 B 2,076.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.43 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$90.44 B 356.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$438.03 B 2,109.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
NZ$16.68 B-15.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$877.80 B 4,328.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.12 B-74.13%๐Ÿ‡บ๐Ÿ‡ธ USA